Thebrewnews19 Aug, 2025News
AstraZeneca has unveiled a landmark plan to invest $50 billion in the U.S. by 2030, its largest-ever single-country commitment. The funds will support a new manufacturing hub in Virginia and expand R&D and cell-therapy facilities across Maryland, Massachusetts, Indiana, California, and Texas—fueling innovation and job growth in America.
Nổ Hũ
B52club
Eclipse Marketing – Los Angeles Seo
Rc88skin
05x Bet Login
Lit Education
Nikolajsen Maddox
75c
Zhu Bailey
99aa